Companies you'll love to work for

Semma Therapeutics
Semma Therapeutics
semma-tx.com

Locations

Massachusetts, USA · Cambridge, MA, USA · Cambridge, MA, USA

industry

Biotechnology · DeepTech · Health

Size

5001+ employees

Stage

Series B

founded in

2015

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.

Something looks off?
Open jobs at Semma Therapeutics
Powered by Getro